摘要
目的观察缺血性脑血管病治疗中应用血塞通联合阿司匹林的临床效果。方法选择我院80例缺血性脑血管病患者实施此次研究,从2017年1月开始,至2018年1月终止,根据随机数字表法分为观察组(40例)和对照组(40例)。观察组使用血塞通联合阿司匹林治疗,对照组使用阿司匹林治疗,比较两组患者临床效果。结果观察组全血黏度、全血低切黏度、纤维蛋白原、红细胞压积指标低于对照组(P<0.05)。观察组治疗4周、8周、12周血压控制率高于对照组(P<0.05)。观察组总有效率为95.00%,对照组为80.00%(P<0.05)。结论在缺血性脑血管疾病中应用阿司匹林及血塞通联合治疗,可有效提升治疗效果,提升血压控制率,改善血液流变学指标,临床应用及推广价值极高。
Objective To observe the clinical effect of Xuesaitong combined with aspirin in the treatment of ischemic cerebrovascular disease.Methods Eighty patients with ischemic cerebrovascular disease in our hospital were enrolled in this study.They were started in January 2017 and terminated in January 2018.They were divided into observation group(40 cases)and control group according to random number table method(40 cases).The observation group was treated with Xuesaitong and aspirin,and the control group was treated with aspirin.The clinical effects of the two groups were compared.Results The whole blood viscosity,whole blood low cut viscosity,fibrinogen and hematocrit index of the observation group were lower than those of the control group(P<0.05).The blood pressure control rate of the observation group was higher than that of the control group at 4 weeks,8 weeks,and 12 weeks(P<0.05).The total effective rate was 95.00%in the observation group and 80.00%in the control group(P<0.05).Conclusion The combination of aspirin and Xuesaitong in ischemic cerebrovascular disease can effectively improve the therapeutic effect,improve blood pressure control rate,improve blood rheology index,and has high clinical application and promotion value.
作者
杨聿
YANG Yu(Department of Neurology,Ninth People's Hospital of Shenyang,Shenyang 110000,China)
出处
《中国医药指南》
2020年第12期191-192,共2页
Guide of China Medicine
关键词
血塞通
阿司匹林
缺血性脑血管病
血压控制率
Xuesaitong
Aspirin
Ischemic cerebrovascular disease
Blood pressure control rate
